Skip to main content

Zomedica Corp.

ZOMDF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001684144

No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Zomedica Corp. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ZOMDF: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders23110−12
Shares6.61M357.2K5.19M−1.06M (−17.0%)
Value$386.6K$20.7K$209.2K−$156.7K (−42.8%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held Zomedica Corp. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ZOMDF in Q2 2025
InstitutionSharesValue% of portfolio
CoreCap Advisors, LLC4,800$1940.00%
Pandora Wealth, Inc.450$180.00%

Sold out (14)

Institutions that held Zomedica Corp. at the end of Q1 2025 and filed for Q2 2025 without it.

Not filed for Q2 2025 yet (1)

Institutions that held Zomedica Corp. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZOMDF in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Orion Portfolio Solutions, LLC357,151$20.7K